Social engagement
Social engagement: 6.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Ally Bridge Group, Shenzhen Capital Group, ShenZhen GTJA Investment Group, Loayal Valley Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 40% |
| Private equity | 4 | 20% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 7 | 35% |
Recent activity
29 Jun 2026
Product launch
IL-17 monoclonal antibody Qiyoukang® (#gumokimab)
24 Jun 2026
Recognition
31 May 2026
Milestone
regulatory